OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
Qingling Yang, Jingwen Huang, Qiong Wu, et al.
British Journal of Cancer (2014) Vol. 110, Iss. 8, pp. 1958-1967
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells
Alistair Rice, E Cortés, Dariusz Lachowski, et al.
Oncogenesis (2017) Vol. 6, Iss. 7, pp. e352-e352
Open Access | Times Cited: 449

Epithelial-Mesenchymal Transition and Breast Cancer
Yanyuan Wu, Marianna Sarkissyan, Jaydutt V. Vadgama
Journal of Clinical Medicine (2016) Vol. 5, Iss. 2, pp. 13-13
Open Access | Times Cited: 195

New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111824-111824
Open Access | Times Cited: 155

Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development
Yeonho Jo, Nakwon Choi, Kyobum Kim, et al.
Theranostics (2018) Vol. 8, Iss. 19, pp. 5259-5275
Open Access | Times Cited: 162

Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin
Marshall Hunter Joyce, Carolyne Lu, Emily R. James, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 120

Epithelial–Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance
Alex J. Gooding, William P. Schiemann
Molecular Cancer Research (2020) Vol. 18, Iss. 9, pp. 1257-1270
Open Access | Times Cited: 115

Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
Wenrui Wang, Lingyu Zhang, Yangyang Wang, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 10, pp. e3071-e3071
Open Access | Times Cited: 107

MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
Qingling Yang, Yangyang Wang, Xiaohui Lü, et al.
Oncotarget (2014) Vol. 6, Iss. 5, pp. 3268-3279
Open Access | Times Cited: 105

Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters
Vlasta Němcová‐Fürstová, Dana Kopperová, Kamila Balušíková, et al.
Toxicology and Applied Pharmacology (2016) Vol. 310, pp. 215-228
Closed Access | Times Cited: 96

Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
Jia Ma, Binbin Fang, Fanpeng Zeng, et al.
Oncotarget (2015) Vol. 6, Iss. 3, pp. 1740-1749
Open Access | Times Cited: 93

MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells
Yang Liu, Yumei Li, Rui Wang, et al.
Journal of Experimental & Clinical Cancer Research (2016) Vol. 35, Iss. 1
Open Access | Times Cited: 88

Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
Yali Fan, Quanmei Sun, Xia Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 56

Key genes and molecular mechanisms related to Paclitaxel Resistance
Adel I. Alalawy
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 14

Skp2: A critical molecule for ubiquitination and its role in cancer
Tianyang Feng, Ping Wang, Xiling Zhang
Life Sciences (2024) Vol. 338, pp. 122409-122409
Open Access | Times Cited: 12

Mechanisms of Resistance to Cabazitaxel
George E. Durán, Yan C. Wang, E. Brian Francisco, et al.
Molecular Cancer Therapeutics (2014) Vol. 14, Iss. 1, pp. 193-201
Open Access | Times Cited: 84

MicroRNA-451 induces epithelial–mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc
Dongqin Chen, Jiayuan Huang, Kai Zhang, et al.
European Journal of Cancer (2014) Vol. 50, Iss. 17, pp. 3050-3067
Closed Access | Times Cited: 74

Multiple modes of action of eribulin mesylate: Emerging data and clinical implications
Javier Cortés, Patrick Schöffski, Bruce A. Littlefield
Cancer Treatment Reviews (2018) Vol. 70, pp. 190-198
Open Access | Times Cited: 68

Emerging roles of F-box proteins in cancer drug resistance
Linzhi Yan, Min Lin, Shuya Pan, et al.
Drug Resistance Updates (2019) Vol. 49, pp. 100673-100673
Open Access | Times Cited: 66

Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition
Jingjing Sha, Yunpeng Bai, Huy Ngo, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 893-893
Open Access | Times Cited: 45

Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer
Xinfang Yu, Li Zhou, Wenbin Liu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 33

Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior
Xi Cheng, Huo Wu, Zhijian Jin, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 55

The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells
Rui Wang, Yumei Li, Yueyue Hou, et al.
Oncotarget (2015) Vol. 6, Iss. 9, pp. 7000-7010
Open Access | Times Cited: 54

Long noncoding RNA AC073284.4 suppresses epithelial–mesenchymal transition by sponging miR‐18b‐5p in paclitaxel‐resistant breast cancer cells
Yueyue Wang, Lei Yan, Shuo Yang, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 12, pp. 23202-23215
Closed Access | Times Cited: 47

Long noncoding RNA H19 acts as a miR‐340‐3p sponge to promote epithelial‐mesenchymal transition by regulating YWHAZ expression in paclitaxel‐resistant breast cancer cells
Yan Lei, Shuo Yang, Chengxu Yue, et al.
Environmental Toxicology (2020) Vol. 35, Iss. 9, pp. 1015-1028
Closed Access | Times Cited: 42

Page 1 - Next Page

Scroll to top